Syschem (India)

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE121D01036
NSEID:
BSEID: 531173

INR

48.69

0.79 (1.65%)

BSENSE

Dec 19

BSE+NSE Vol: 1.73 k

{
  "main_header": {
    "sid": 161419,
    "name": "Syschem (India)",
    "stock_name": "Syschem (India)",
    "full_name": "Syschem (India) Ltd",
    "name_url": "stocks-analysis/syschem-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "48.69",
    "chg": 0.79,
    "chgp": "1.65%",
    "dir": 1,
    "prev_price": "47.90",
    "mcapval": "207.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531173,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE121D01036",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "1.73 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syschem-india-161419-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Syschem (India) falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-syschem-india-fallingrising-3754303",
        "imagepath": "",
        "date": "2025-12-10 00:26:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Comparison</strong></p>\n<p>Syschem’s recent price action has been underwhelming compared to the broader market benchmark, the Sensex. Over the past week, the stock has declined by 9.75%, significantly underperforming the Sensex’s modest 0.55% loss. The one-month trend is even more pronounced, with Syschem falling 18.06% while the Sensex gained 1.74%. Year-to-date, the stock is down 2.68%, contrasting with the Sensex’s 8.35% rise. These figures indicate that the stock is facing considerable headwinds in the near term, despite outperforming the Sensex over the last year with a 6.07% gain versus 3.87% for the benchmark.</p>\n<p>Longer-term returns show a more favourable picture for Syschem, with a five-year gain of 695.87%, vastly outpacing the Sensex’s 83.64..."
      },
      {
        "title": "Syschem (India) Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syschem-india-downgraded-to-hold-as-mojo-score-declines-amid-valuation-concerns-3743960",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyschemIndia_mojoScore_3743960.png",
        "date": "2025-12-03 11:08:25",
        "description": "Syschem (India), a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced view of its recent financial and technical performance. This adjustment comes amid a backdrop of strong operating profit growth contrasted with valuation concerns and moderate management efficiency."
      },
      {
        "title": "How has been the historical performance of Syschem (India)?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-syschem-india-3693708",
        "imagepath": "",
        "date": "2025-11-12 23:11:04",
        "description": "Answer:\nThe historical performance of Syschem (India) shows significant fluctuations in key financial metrics over the years, particularly in net sales, operating profit, and profit after tax.\n\nBreakdown:\nSyschem (India) has experienced a notable increase in net sales, rising from 59.00 Cr in Mar'22 to 331.68 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar trend, reaching 331.68 Cr in Mar'25, up from 59.00 Cr in Mar'22. However, the company's total expenditure also increased significantly, from 58.44 Cr in Mar'22 to 327.69 Cr in Mar'25, primarily driven by rising raw material costs, which surged from 46.97 Cr in Mar'22 to 310.87 Cr in Mar'25. Operating profit (PBDIT) showed volatility, peaking at 8.90 Cr in Mar'23 but dropping to 4.03 Cr in Mar'25. Profit before tax also fluctuated, with a high of 6.15 Cr in Mar'23 and a decline to 1.01 Cr in Mar'25. Profit aft..."
      },
      {
        "title": "Are Syschem (India) latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-syschem-india-latest-results-good-or-bad-3690415",
        "imagepath": "",
        "date": "2025-11-11 19:29:28",
        "description": "Syschem (India) has reported notable financial results for the quarter ended September 2025, showcasing significant year-on-year growth in both net sales and net profit. The company achieved a net sales growth of 118.01%, rising from ₹103.60 crores in September 2024 to a substantial figure in the latest quarter. This growth reflects the company's ability to capitalize on demand within the pharmaceutical sector, particularly in the API market.\n\nIn terms of profitability, Syschem's standalone net profit surged by 396.88%, indicating a strong recovery from the previous year's loss. The operating profit margin, although improved to 3.04%, remains a point of concern as it is still relatively low for a manufacturing entity. This suggests that while the company is generating higher revenues, the efficiency in converting these revenues into profit is still fragile.\n\nThe financial data also highlights an adjustment ..."
      },
      {
        "title": "Syschem (India) Q1 FY26: Revenue Surge Masks Persistent Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/syschem-india-q1-fy26-revenue-surge-masks-persistent-profitability-concerns-3686732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyschemIndia_quaterlyResult_3686732.png",
        "date": "2025-11-10 19:31:07",
        "description": "Syschem (India) Ltd., a micro-cap pharmaceutical API and intermediates manufacturer, reported net profit of ₹1.67 crores for Q1 FY26 (Apr-Jun'25), marking a dramatic turnaround from ₹0.14 crores in the year-ago quarter—a staggering 1,092.86% year-on-year surge. However, the sequential picture reveals fragility: profits jumped 263.04% quarter-on-quarter from ₹0.46 crores in Q4 FY25, but this follows an exceptionally weak base marked by a loss-making Q3 FY25."
      },
      {
        "title": "Syschem (India) Ltd Surges 5% Today, Up 35.98% Over Last Three Months Amid Strong Buying Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syschem-india-ltd-surges-5-today-up-3598-over-last-three-months-amid-strong-buying-activity-3670999",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyschemIndia_only_buyers_3670999.png",
        "date": "2025-11-04 11:50:05",
        "description": "Syschem (India) Ltd is experiencing notable buying activity, with a significant rise in its stock price today, contrasting with a decline in the Sensex. Over the past week, Syschem has shown strong performance, outperforming its sector and trading above key moving averages, indicating robust market positioning."
      },
      {
        "title": "Syschem (India) Faces Mixed Technical Indicators Amidst Strong Growth and Operational Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syschem-india-stock-rating-downgraded-from-buy-to-hold-by-marketsmojo-3669547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyschemIndia_mojoScore_3669547.png",
        "date": "2025-11-04 08:20:13",
        "description": "Syschem (India), a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment. The company has shown significant growth, with net sales rising by 37.96% and net profit soaring by 1092.86%. However, it faces challenges in management efficiency, indicated by a low return on equity."
      },
      {
        "title": "How has been the historical performance of Syschem (India)?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-syschem-india-3667950",
        "imagepath": "",
        "date": "2025-11-03 22:43:58",
        "description": "Answer:\nThe historical performance of Syschem (India) shows significant fluctuations in key financial metrics over the years, particularly in net sales, profits, and overall financial health.\n\nBreakdown:\nSyschem (India) has experienced a notable increase in net sales, rising from 59.00 Cr in Mar'22 to 331.68 Cr in Mar'25, reflecting a strong growth trajectory. However, the total operating income followed a similar trend, reaching 331.68 Cr in Mar'25, up from 59.00 Cr in Mar'22. The raw material costs have also surged, peaking at 310.87 Cr in Mar'25, which has impacted the operating profit, which was 3.99 Cr in Mar'25, down from 8.65 Cr in Mar'23. The profit before tax has shown a decline from 6.15 Cr in Mar'23 to 1.01 Cr in Mar'25, while profit after tax decreased from 4.51 Cr in Mar'23 to 0.46 Cr in Mar'25. The company's total liabilities increased significantly from 55.87 Cr in Mar'22 to 216.87 Cr in Mar'..."
      },
      {
        "title": "Syschem (India) Ltd Surges 4.99%, Reverses Decline with 27.57% Gain Over Three Months",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syschem-india-ltd-surges-499-reverses-decline-with-2757-gain-over-three-months-3666883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyschemIndia_only_buyers_3666883.png",
        "date": "2025-11-03 15:10:07",
        "description": "Syschem (India) Ltd is experiencing notable buying activity, with a significant rise today, reversing a two-day decline. The stock has shown strong performance over the past week and months, significantly outperforming the Sensex. Factors contributing to this trend include consistent performance above moving averages and increased interest in the microcap pharmaceutical sector."
      }
    ],
    "total": 95,
    "sid": "161419",
    "stock_news_url": "https://www.marketsmojo.com/news/syschem-india-161419"
  },
  "announcements": [
    {
      "caption": "As Per Regulation 47 Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) 2015 Newspaper Publication For The Quarter 2 Results.",
      "datetime": "11-Nov-2025",
      "details": "As per regulation 47 read with schedule iii of SEBI (Listing Obligations and Disclosure requirements) 2015newspaper publication for the quarter 2.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Results_Q2 September 2025: Outcome Of Board Meeting",
      "datetime": "10-Nov-2025",
      "details": "Outcome of Board Meeting: Result _Q2; September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Results For The Quarter Ending 30Th September 2025",
      "datetime": "10-Nov-2025",
      "details": "Declaration of results for the Quarter and half year ending 30th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syschem (India) Ltd has announced <strong>10:1</strong> stock split, ex-date: 12 Dec 14",
          "dt": "2014-12-12",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syschem (India) Ltd has announced <strong>1:4</strong> rights issue, ex-date: 28 Sep 23",
          "dt": "2023-09-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Syschem (India) falling/rising?

2025-12-10 00:26:59

Short-Term Price Movement and Market Comparison

Syschem’s recent price action has been underwhelming compared to the broader market benchmark, the Sensex. Over the past week, the stock has declined by 9.75%, significantly underperforming the Sensex’s modest 0.55% loss. The one-month trend is even more pronounced, with Syschem falling 18.06% while the Sensex gained 1.74%. Year-to-date, the stock is down 2.68%, contrasting with the Sensex’s 8.35% rise. These figures indicate that the stock is facing considerable headwinds in the near term, despite outperforming the Sensex over the last year with a 6.07% gain versus 3.87% for the benchmark.

Longer-term returns show a more favourable picture for Syschem, with a five-year gain of 695.87%, vastly outpacing the Sensex’s 83.64...

Syschem (India) Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-03 11:08:25

Syschem (India), a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced view of its recent financial and technical performance. This adjustment comes amid a backdrop of strong operating profit growth contrasted with valuation concerns and moderate management efficiency.

How has been the historical performance of Syschem (India)?

2025-11-12 23:11:04

Answer: The historical performance of Syschem (India) shows significant fluctuations in key financial metrics over the years, particularly in net sales, operating profit, and profit after tax. Breakdown: Syschem (India) has experienced a notable increase in net sales, rising from 59.00 Cr in Mar'22 to 331.68 Cr in Mar'25, reflecting a strong growth trajectory. Total operating income followed a similar trend, reaching 331.68 Cr in Mar'25, up from 59.00 Cr in Mar'22. However, the company's total expenditure also increased significantly, from 58.44 Cr in Mar'22 to 327.69 Cr in Mar'25, primarily driven by rising raw material costs, which surged from 46.97 Cr in Mar'22 to 310.87 Cr in Mar'25. Operating profit (PBDIT) showed volatility, peaking at 8.90 Cr in Mar'23 but dropping to 4.03 Cr in Mar'25. Profit before tax also fluctuated, with a high of 6.15 Cr in Mar'23 and a decline to 1.01 Cr in Mar'25. Profit aft...

Are Syschem (India) latest results good or bad?

2025-11-11 19:29:28

Syschem (India) has reported notable financial results for the quarter ended September 2025, showcasing significant year-on-year growth in both net sales and net profit. The company achieved a net sales growth of 118.01%, rising from ₹103.60 crores in September 2024 to a substantial figure in the latest quarter. This growth reflects the company's ability to capitalize on demand within the pharmaceutical sector, particularly in the API market. In terms of profitability, Syschem's standalone net profit surged by 396.88%, indicating a strong recovery from the previous year's loss. The operating profit margin, although improved to 3.04%, remains a point of concern as it is still relatively low for a manufacturing entity. This suggests that while the company is generating higher revenues, the efficiency in converting these revenues into profit is still fragile. The financial data also highlights an adjustment ...

Syschem (India) Q1 FY26: Revenue Surge Masks Persistent Profitability Concerns

2025-11-10 19:31:07

Syschem (India) Ltd., a micro-cap pharmaceutical API and intermediates manufacturer, reported net profit of ₹1.67 crores for Q1 FY26 (Apr-Jun'25), marking a dramatic turnaround from ₹0.14 crores in the year-ago quarter—a staggering 1,092.86% year-on-year surge. However, the sequential picture reveals fragility: profits jumped 263.04% quarter-on-quarter from ₹0.46 crores in Q4 FY25, but this follows an exceptionally weak base marked by a loss-making Q3 FY25.

Syschem (India) Ltd Surges 5% Today, Up 35.98% Over Last Three Months Amid Strong Buying Activity

2025-11-04 11:50:05

Syschem (India) Ltd is experiencing notable buying activity, with a significant rise in its stock price today, contrasting with a decline in the Sensex. Over the past week, Syschem has shown strong performance, outperforming its sector and trading above key moving averages, indicating robust market positioning.

Syschem (India) Faces Mixed Technical Indicators Amidst Strong Growth and Operational Challenges

2025-11-04 08:20:13

Syschem (India), a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment. The company has shown significant growth, with net sales rising by 37.96% and net profit soaring by 1092.86%. However, it faces challenges in management efficiency, indicated by a low return on equity.

How has been the historical performance of Syschem (India)?

2025-11-03 22:43:58

Answer: The historical performance of Syschem (India) shows significant fluctuations in key financial metrics over the years, particularly in net sales, profits, and overall financial health. Breakdown: Syschem (India) has experienced a notable increase in net sales, rising from 59.00 Cr in Mar'22 to 331.68 Cr in Mar'25, reflecting a strong growth trajectory. However, the total operating income followed a similar trend, reaching 331.68 Cr in Mar'25, up from 59.00 Cr in Mar'22. The raw material costs have also surged, peaking at 310.87 Cr in Mar'25, which has impacted the operating profit, which was 3.99 Cr in Mar'25, down from 8.65 Cr in Mar'23. The profit before tax has shown a decline from 6.15 Cr in Mar'23 to 1.01 Cr in Mar'25, while profit after tax decreased from 4.51 Cr in Mar'23 to 0.46 Cr in Mar'25. The company's total liabilities increased significantly from 55.87 Cr in Mar'22 to 216.87 Cr in Mar'...

Syschem (India) Ltd Surges 4.99%, Reverses Decline with 27.57% Gain Over Three Months

2025-11-03 15:10:07

Syschem (India) Ltd is experiencing notable buying activity, with a significant rise today, reversing a two-day decline. The stock has shown strong performance over the past week and months, significantly outperforming the Sensex. Factors contributing to this trend include consistent performance above moving averages and increased interest in the microcap pharmaceutical sector.